Display Settings:

Format

Send to:

Choose Destination
    Kidney Int. 2010 Feb;77(3):175-7.

    Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure.

    Source

    Winthrop-University Hospital, Mineola, New York, USA. sfishbane@metrorenal.com

    Abstract

    Anemia is common in chronic kidney disease (CKD). The CHOIR study found increased risk of a composite cardiovascular outcome when anemia was treated with epoetin-alfa to a target hemoglobin level of 13.5 as compared with 11.3 g/dl. Whether this increase applies to all patient subgroups equally is unclear. We discuss an analysis by Szczech and colleagues of the effects of the higher hemoglobin target in CKD patients with diabetes mellitus or congestive heart failure.

    PMID:
    20075952
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk